医疗第二意见市场概览、增长、趋势、分析、研究报告(2023-2031 年)

  • Report Code : TIPRE00011728
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 135
Buy Now

Medical Second Opinion Market Scope 2031

Buy Now

预计到 2031 年,医疗第二意见市场规模将从 2023 年的 53.3 亿美元增至 154.0 亿美元。预计 2023-2031 年期间,该市场的复合年增长率将达到 14.2%。医疗咨询服务的日益数字化可能会在未来几年为医疗第二意见市场带来新的趋势。

第二医疗意见市场分析

推动第二医学意见市场发展的因素包括对更好治疗结果的日益重视和对医疗成本优化的日益偏好。此外,新兴经济体对各种呼吸系统疾病的认识不断提高,对第二医学意见的倾向不断增加,预计也将进一步促进市场增长。此外,远程医疗技术合作的不断增加预计将在未来几年创造充足的机会。

第二医疗意见市场概览

市场增长归因于人们越来越重视更好的治疗结果和越来越倾向于优化医疗成本。预计北美将主导第二医疗意见市场,而亚太地区预计将由于慢性病患病率不断上升和政府举措不断增加而实现显着增长率。中国占据主要市场份额。预计印度在预测期内将实现显着增长率。近年来,印度的癌症病例数显着增加。根据 Globocan 2020,该国新发癌症病例数为 1,324,413 例。该国报告的最常见癌症类型包括乳腺癌、肺癌、白血病和非霍奇金淋巴瘤等。因此,印度慢性病患病率的不断上升可能会加速对第二医疗意见的需求,以避免对临床症状的误解。根据印度癌症解放基金会(一家位于德里的非政府组织)对 2024 年 3 月至 5 月期间拨打热线电话的 1,769 名全国癌症患者进行的调查,免费的国家癌症帮助热线号码的开通已被证明是全国癌症患者的支持系统。此外,ETHealthworld 在 2024 年 6 月的数据显示,在私立医院接受治疗的癌症患者中约有 67% 和在公立医院接受治疗的癌症患者中约有 33% 寻求第二意见,以确定他们的治疗是否正确,并检查是否有最新治疗方案。

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

医疗第二意见市场:

医疗第二意见市场
  • Medical Second Opinion Market
    复合年增长率(2023 - 2031)
    14.2%
  • 2023 年市场规模
    53.3 亿美元
  • 2031年市场规模
    154亿美元

市场动态

增长动力
  • 越来越重视更好的治疗效果有利于市场增长
未来趋势
  • 医疗咨询服务日益数字化预计将成为未来几年的趋势
机会
  • 远程医疗技术领域的合作日益增多,很可能在未来几年创造大量机遇

关键人物

  • Medisense 医疗保健解决方案私人有限公司
  • 第二意见国际
  • 精英医疗服务
  • 信诺集团
  • 赫尔萨娜
  • 世健
  • 维达尔健康保险TPA私人有限公司
  • 梅迪克斯
  • 第二任医学博士
  • 法国安盛集团

区域概况

Medical Second Opinion Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Medical Second Opinion Market健康)状况
  • 癌症
  • 骨科疾病
  • 心脏疾病
  • 神经系统疾病
  • 肾脏疾病
  • 血液系统疾病
  • 慢性阻塞性肺病
  • 器官移植
Medical Second Opinion Market服务提供商
  • 医院
  • 健康保险公司
  • 在线服务
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

第二医学意见市场驱动因素和机遇

医疗成本优化偏好日益增加

全球各地的患者都目睹了医疗保健服务带来的日益沉重的经济负担。由于医疗保健专业人员总体短缺和资源有限,医疗保健相关成本不断增加,这促使全球对医疗保健成本进行优化的需求。此外,越来越重视减少额外成本,并越来越意识到医疗保健组织可能存在的剥削,尤其是在低收入和中等收入国家,这极大地推动了第二医疗意见市场的发展。消费者可以在对手术或主要病例做出必要决定时,从第二医疗意见中获得大量信息。此外,第二医疗意见提供者会根据额外的医疗诊断、对现有医疗记录的分析以及对作为手术替代方案的其他治疗方案的评估来审查手术程序的建议。第二意见的这些方面可以降低治疗成本。对手术决策的第二意见可以减少可能的手术逆境,从而降低额外的医疗保健相关成本。例如,根据 Cureus 在 2022 年发表的一项研究,全球约 31% 的患者在手术过程中出现并发症。此外,根据 2023 年 3 月发表的《开放内科医学杂志》的数据,每年约有 420 万人术后死亡,占全球死亡率的 7.7%。因此,预计所有上述因素都将在未来几年促进市场增长。

远程医疗技术合作日益增多

远程医疗技术利用现代通信平台在患者和医疗专业人员之间进行虚拟互动。远程医疗技术可以采用两种不同的方法:实时交互和存储转发方法。远程医疗技术使医生和患者能够不受地理界限的约束进行交流。远程医疗技术带来的好处和投资的增加可能会为医疗第二意见市场提供有利可图的机会。例如,2024 年 6 月,IMG 与 Teladoc Health 合作,通过提供与医疗专业人员的虚拟访问,无论他们身在何处,都可以增强 IMG 客户的福祉。它还将为具有现有远程医疗服务的 IMG 客户扩展远程医疗服务能力,并将远程医疗服务引入其他 IMG 计划。2023 年 7 月,AMD Global Telemedicine Inc. 与 Collain Healthcare 合作提供电子健康记录 (EHR) 解决方案,并结合重要解决方案,彻底改变老年生活设施中的医疗保健服务,提供实时信息,减少错误并简化临床工作流程。此外,2024 年 2 月,在印度,印度理工学院坎普尔分校与北方邦政府合作,利用人工智能加强远程医疗。谅解备忘录强调了几个关键的合作领域,包括巩固远程医疗中心和提高远程医疗服务质量,实施基于人工智能的解决方案来解决公共卫生问题。远程医疗技术领域的伙伴关系和合作数量不断增加,预计将在未来几年为市场增长提供丰厚的机会。

医疗第二意见市场报告细分分析

有助于得出医疗第二意见市场分析的关键部分是条件和服务提供商。

  • 根据情况,第二医学意见市场分为癌症、骨科疾病、心脏病、神经系统疾病、肾病、血液系统疾病、慢性阻塞性肺病、器官移植等。癌症领域在 2023 年占据了最大的市场份额。预计骨科疾病领域在 2023-2031 年期间的复合年增长率最高。
  • 按服务提供商划分,医疗第二意见市场分为医院、健康保险公司和在线服务。医院部门在 2023 年占据了最大的市场份额。预计健康保险公司部门将在 2023-2031 年期间实现最高的复合年增长率。

按地区划分的第二医疗意见市场份额分析

医疗第二意见市场报告的地理范围主要分为五个区域:北美、亚太、欧洲、中东和非洲、南美和中美。

2023 年,北美占据了相当大的市场份额。该地区市场的增长归因于医疗第二意见服务的日益普及和医疗咨询服务的日益数字化。此外,由于医疗保健系统的发展和对改善治疗结果的日益重视,预计区域市场将增长。由于癌症患病率不断上升,预计美国将占据最大的市场份额。癌症是该国第二大死亡原因。根据美国癌症协会的数据,2022 年,美国诊断出超过 190 万例新癌症病例,导致约 609,360 人死亡。此外,预计 2024 年美国将有约 200 万人被诊断出患有癌症。误诊癌症病例的增加及其不良影响正在推动对医疗第二意见的需求。

根据约翰霍普金斯大学的研究,美国每年约有 4,000 起手术失误。此外,根据一项名为“导致死亡的十大医疗失误”的研究,美国每年约有 7,000 至 9,000 名患者因用药错误而死亡。根据 2023 年 7 月发表的文章“美国诊断错误造成的严重伤害负担”,每年约有 795,000 名美国人因严重疾病的误诊而受苦。如此高的医疗失误数量预计将使该国对医疗第二意见的需求激增。

医疗第二意见市场报告范围

报告属性细节
2023 年的市场规模53.3亿美元
2031 年市场规模154亿美元
全球复合年增长率(2023 - 2031)14.2%
史料2021-2022
预测期2024-2031
涵盖的领域按条件
  • 癌症
  • 骨科疾病
  • 心脏疾病
  • 神经系统疾病
  • 肾脏疾病
  • 血液系统疾病
  • 慢性阻塞性肺病
  • 器官移植
按服务提供商
  • 医院
  • 健康保险公司
  • 在线服务
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • Medisense 医疗保健解决方案私人有限公司
  • 第二意见国际
  • 精英医疗服务
  • 信诺集团
  • 赫尔萨娜
  • 世健
  • 维达尔健康保险TPA私人有限公司
  • 梅迪克斯
  • 第二任医学博士
  • 法国安盛集团
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

第二医学意见市场新闻和最新发展

医疗第二意见市场通过收集一手和二手研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。医疗第二意见市场的一些发展如下:

  • Included Health 推出了综合医疗服务平台,其中包括专科护理诊所,这是一家多中心、虚拟优先的诊所,可快速联系医疗专家并为最普遍和最昂贵的专科护理需求提供全面支持。专科护理诊所是 Included Health 专家医疗意见服务的演变,以提供准确诊断和量身定制的治疗计划而闻名。(来源:Included Health, Inc.,公司网站,2024 年 4 月)
  • 2nd.MD 与 UnitedHealthcare 合作,为会员提供免费、以会员为中心的专家医疗意见服务。2nd.MD 将面临严重或昂贵医疗保健决策的会员与该领域的顶级专家进行虚拟联系,以审查他们的病例并就最佳选择提供第二意见。通过 2nd.MD,符合条件的会员可以与专家联系,深入了解他们的病情并探索治疗方案。(来源:2nd.MD,公司网站,2023 年 11 月)

医疗第二意见市场报告覆盖范围和交付成果

“医疗第二意见市场规模和预测(2021-2031 年)”报告对以下领域进行了详细的市场分析:

  • 范围内涵盖的所有主要细分市场的全球、区域和国家/地区第二医疗意见市场规模和预测
  • 医疗第二意见市场趋势,以及驱动因素、限制因素和关键机遇等市场动态
  • 详细的 PEST 和 SWOT 分析
  • 医疗第二意见市场分析涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,涵盖市场集中度、热点图分析、知名参与者以及医疗第二意见市场的最新发展
  • 详细的公司简介
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is medical second opinion?

A medical second opinion is the process through which a patient seeks another professional assessment or evaluation of a diagnosed case, a treatment, or a medical condition by a different provider. This helps patients confirm a diagnosis, seek alternative treatment options, and be reassured about the decisions they make with respect to their health. Getting a second opinion is especially true for serious conditions, complex medical cases, and the uncertainty of a patient in relation to the first recommendation they received. This is apt to empower patients by giving them more information as well as perspectives on their health status.

Who are the major players in the medical second opinion market?

The medical second opinion market majorly consists of the players such as Medisense Healthcare Solutions Pvt. Ltd.; Second Opinion International; Elite Medical Services; The Cigna Group; Helsana; WorldCare; Vidal Health Insurance TPA Pvt Ltd; Medix; 2nd.MD; Axa SA; Teladoc Health Inc; DoctorSpring Pvt. Ltd; USARAD Holdings Inc (SecondOpinions.com); Cleveland Clinic; Included Health, Inc.; Mass General Brigham Incorporated. (Partners Healthcare); Stanford Health Care; and Royal Doctors

What are the driving factors for the medical second opinion market?

Key factors that are driving the growth of the market are the growing emphasis on better treatment outcomes and an increasing preference for healthcare cost optimization.

Which segment is dominating the medical second opinion market?

Based on condition, cancer segment dominated the market growth during 2023-2031. By service provider, hospitals segment dominated the market growth during 2023-2031.

What are the growth estimates for the medical second opinion market till 2031?

The medical second opinion market is expected to be valued at US$ 15.40 bllion in 2031.

What was the estimated medical second opinion market size in 2023?

The medical second opinion market was valued at US$ 5.33 billion in 2023.

The List of Companies - Medical Second Opinion Market

  1. Medisense Healthcare Solutions Pvt. Ltd.
  2. Second Opinion International
  3. Elite Medical Services
  4. The Cigna Group
  5. Helsana
  6. WorldCare
  7. Vidal Health Insurance TPA Pvt Ltd
  8. Medix
  9. 2nd.MD
  10. Axa SA

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Pharmaceuticals : READ MORE..